ClinicalTrials.Veeva

Menu

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

A

Ain Shams University

Status

Enrolling

Conditions

Neutrophils to Lymphocytes
Septic Patients
Procalcitonin
Prognostic Outcome
Total Leucocytic Count
Platelets
Intensive Care Unit

Treatments

Diagnostic Test: Neutrophils to Lymphocytes and Platelets ratio (N/LP)

Study type

Observational

Funder types

Other

Identifiers

NCT07200817
FMASU MD224/2024

Details and patient eligibility

About

This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.

Full description

Sepsis affects more than 30 million people annually worldwide and is one of the significant causes of death in critical patients worldwide. Any infected person can potentially develop sepsis, and the incidence of sepsis is as high as 1-2% of all hospitalized patients.

Many potential sepsis biomarkers have been proposed, procalcitonin (PCT) and C-reactive protein (CRP) being the most frequently studied.

The ratio of neutrophils to lymphocytes and platelets (N/LP) is a low-cost measure that can be obtained through routine blood tests and is often used to reflect the body's inflammatory state.

Enrollment

290 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age from 18 to 70 years old.
  • Both sexes.
  • Septic patients (under the third international consensus definitions of sepsis and septic shock).

Exclusion criteria

  • Pregnancy
  • Malignancy
  • On immunosuppressive therapy
  • Hematological Disorders
  • Major Trauma
  • Major Burns
  • Child-Pugh Class C Liver Cirrhosis
  • On Hemodialysis

Trial design

290 participants in 1 patient group

Study group
Description:
Septic patients (under the third international consensus definitions of sepsis and septic shock)
Treatment:
Diagnostic Test: Neutrophils to Lymphocytes and Platelets ratio (N/LP)

Trial contacts and locations

1

Loading...

Central trial contact

Michael G Farag, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems